Alzheimer's Talks

A free teleconference series offered by UsAgainstAlzheimer's covering a wide range of topics with leaders in the Alzheimer's community. If you're interested in sponsoring a call, email

Latest Talks

June 13, 2016

Alzheimer's Prevention Initiative - Dr. Eric Reiman

Dr. Eric Reiman, the Executive Director of Banner Alzheimer’s Institute, joined this Alzheimer’s Talks to discuss his research to prevent Alzheimer’s disease, including two clinical trials that the Alzheimer’s Prevention Initiative has underway and the need to recruit more people into Alzheimer's clinical trials to speed these efforts.

Dr. Reiman and his colleagues have made pioneering contributions in brain imaging research, the earliest detection and tracking of Alzheimer's disease...

May 16, 2016

On My Own - Diane Rehm

Journalist, radio talk show host, and author Diane Rehm spoke with UsAgainstAlzheimer's Co-Founder and Chairman George Vradenburg about her new book, On My Own, which is a deeply personal, profoundly moving, and incredibly honest book about her life before and after her husband’s death with Parkinson’s disease.

Diane is a recipient of the National Humanities Medal as well as a Personal Peabody Award, considered among the most prestigious and selective...

April 11, 2016

The Alzheimer's Drug Pipeline - Dr. David Morgan

A new analysis released by our ResearchersAgainstAlzheimer’s network shows that 17 new Alzheimer’s drugs could be on the market within the next five years.

Drew Holzapfel, Director of ResearchersAgainstAlzheimer’s, and Dr. David Morgan, CEO of the Byrd Alzheimer’s Institute and a founding member of ResearchersAgainstAlzheimer’s, joined us for this month’s Alzheimer’s Talks to discuss the study, "Will the Next Five Years Witness an Innovation Wave in Medicines for Alzheimer’s?”


March 8, 2016

MINDSET Trial - Dr. Lawrence Friedhoff

Dr. Lawrence Friedhoff from Axovant Sciences was our guest for this Alzheimer’s Talks. Dr. Friedhoff has worked in pharmaceutical research and development for more than thirty years. He has led teams that developed and obtained approval for six new drugs, including donepezil (commonly known as Aricept) and he is also the author of the book New Drugs: An Insider’s Guide to the FDA Approval Process for Scientists, Investors, and Patients...